This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Washington. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Christopher David Bahl: Innovator in Influenza Treatment
Introduction
Christopher David Bahl is a prominent inventor based in Seattle, Washington. He has made significant contributions to the field of virology, particularly in the development of treatments for influenza. His innovative work has the potential to impact public health positively.
Latest Patents
Bahl holds a patent for "De novo designed hemagglutinin binding proteins." This patent discloses polypeptides that bind to viral hemagglutinin, along with methods for their use in treating or limiting influenza infection and diagnosing influenza infection. This invention represents a crucial advancement in the fight against influenza.
Career Highlights
Bahl is affiliated with the University of Washington, where he conducts research and develops innovative solutions to combat viral infections. His work is characterized by a commitment to scientific excellence and a focus on practical applications of his research.
Collaborations
Bahl has collaborated with notable researchers, including David Baker and Aaron Arthur Chevalier. These partnerships have enhanced the scope and impact of his research efforts.
Conclusion
Christopher David Bahl is a key figure in the development of novel treatments for influenza, with a patent that showcases his innovative approach to virology. His work at the University of Washington and collaborations with esteemed colleagues further highlight his contributions to the field.